Form 4 for REVB REVELATION BIOSCIENCES, INC.
Accepted 2025-10-31 00:00:00 ET · period of report 2025-10-29 · accession 0001193125-25-260417 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-10-31 | 2025-10-29 | REVB | Zygmont Chester Stanley III | CFO | A - Grant | $1.28 | +390.6K | 395.6K | +7,764% | +$500.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-29 | A | A | 390,614 | $1.28 | 395,645 | I By Trust | — | — | (F1) Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests quarterly over one year from the date of grant. (F2) Shares are held by The Zygmont Family Trust Dated October 25, 2016, with respect to which Chester S Zygmont III is a trustee. |